We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Proteome Sciences Plc | LSE:PRM | London | Ordinary Share | GB0003104196 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.64 | 18.23% | 4.15 | 3.50 | 4.80 | - | 423,867 | 16:35:28 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 7.78M | 1.33M | 0.0045 | 7.80 | 10.36M |
Date | Subject | Author | Discuss |
---|---|---|---|
07/2/2024 13:43 | yes, it cant be arboricultural due to lack of trees standing | elpirata | |
07/2/2024 13:41 | If you will forgive me, all of this ramping comes across as a bit - how can I put this - ‘agricultural& | monte1 | |
07/2/2024 10:46 | I note that #59606 has 4 Thumbs ups, actually make that 5! | james japp | |
07/2/2024 10:42 | Quite, I wonder how well that strategy has worked out for previous investors*? *suckers | monte1 | |
07/2/2024 10:21 | Riiiiiight. | james japp | |
07/2/2024 10:20 | Investors need to buy these while there's no demand, otherwise they'll be paying a lot more for them after the news is released. | wasjobber | |
07/2/2024 10:17 | I wonder if there has ever been a less convincing case for labeling a stock a "STRONG BUY" than this? No trades at all on Monday, just 2 all day yesterday totaling around £500 worth of stock and none again so far today. | james japp | |
07/2/2024 10:12 | Proteome Sciences should get their new isotopic plexDIA reagent license deal very soon. This opens up a whole new market segment of mass spec users keen to multiplex their measurements. Of course the release of their new 32-plex TMTpro is also due soon. I don't think many investors on here have fully understood the positive implications for Proteome Sciences of all these higher plexing reagents that are imminent. STRONG BUY | wasjobber | |
06/2/2024 01:12 | Martin, yes...Stephen, no. | canaletto | |
06/2/2024 01:11 | I will never get over how Stephen Diggle fell for the CJP snake oil salesman pitch. | canaletto | |
05/2/2024 22:54 | When is this US listing due,and at what price will it float or will it be mothballed like everything else.Where is this Stroke test that never gets a mention anymore. | peverill | |
01/2/2024 23:50 | Could be a revisit to 3.5/3p area coming. | peverill | |
01/2/2024 17:15 | Probably true but not a tautology or there again . Quite a puzzling statement . | alchemy | |
01/2/2024 14:56 | I disagree. | goatherd | |
01/2/2024 13:13 | FSE was on the money as was NNN. Goatherd should be eating humble pie for breakfast lunch and dinner... | coldale1 | |
31/1/2024 13:34 | Good thread this. | small crow | |
31/1/2024 12:47 | goatherd - 07 Jul 2003 - 08:39:00 - 18128 of 33240 Proteome Sciences results in big news CJD + Stroke tests - PRM Tuco, I do take your point but I am not interested in a private conversation with FSE. I am interested in not letting him get away with claims like "I think we are all agreed that Proteome is medium to high risk". I for one am not - and I think Peter Snodgrass is not either. If FSE does not post I will not pursue him; or if someone else points out where he is wrong I will be glad to hand the batten over! Richard | james japp | |
31/1/2024 12:37 | Canaletto, My reporting may have been at fault. I believe what I actually said was more like "I expect six - - - " which I think even you would agree was not a lie. Unfortunately I have not the time to research it back. Perhaps I should amend my statement to "I never knowingly lie". But that, I think would be a tautology. | goatherd | |
31/1/2024 12:27 | goatherd 31 Jan '24 - 12:24 - 4365 of 4365 | james japp | |
31/1/2024 11:34 | Arraws Canaletto. | james japp | |
31/1/2024 07:53 | I never lie............. I did report this, but because I like to be conservative, I said it was six projects. | canaletto |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions